These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Methodological advances and plans for improving regulatory success for confirmatory studies. Koch GG; Davis SM; Anderson RL Stat Med; 1998 Aug 15-30; 17(15-16):1675-90. PubMed ID: 9749439 [TBL] [Abstract][Full Text] [Related]
28. All that is measured may not help. Gross M Can J Surg; 2000 Dec; 43(6):406. PubMed ID: 11129824 [No Abstract] [Full Text] [Related]
29. Improving the quality of randomized controlled trials in Chinese herbal medicine, part I: clinical trial design and methodology. Bian ZX; Li YP; Moher D; Dagenais S; Liu L; Wu TX; Miao JX; Kwan AK; Song L Zhong Xi Yi Jie He Xue Bao; 2006 Mar; 4(2):120-9. PubMed ID: 16529686 [TBL] [Abstract][Full Text] [Related]
30. Perspective: US Documentation and Regulation of Human Nutrition Randomized Controlled Trials. Weaver CM; Fukagawa NK; Liska D; Mattes RD; Matuszek G; Nieves JW; Shapses SA; Snetselaar LG Adv Nutr; 2021 Feb; 12(1):21-45. PubMed ID: 33200185 [TBL] [Abstract][Full Text] [Related]
31. The management of interim analyses in drug development. Facey KM; Lewis JA Stat Med; 1998 Aug 15-30; 17(15-16):1801-9; discussion 1811-2. PubMed ID: 9749448 [TBL] [Abstract][Full Text] [Related]
32. Evaluating health promotion: a tale of three errors. Tones K Patient Educ Couns; 2000 Feb; 39(2-3):227-36. PubMed ID: 11040722 [TBL] [Abstract][Full Text] [Related]
33. Quality assurance of data collection in the multi-site community randomized trial and prevalence survey of the children's healthy living program. Yamanaka A; Fialkowski MK; Wilkens L; Li F; Ettienne R; Fleming T; Power J; Deenik J; Coleman P; Leon Guerrero R; Novotny R BMC Res Notes; 2016 Sep; 9(1):432. PubMed ID: 27590179 [TBL] [Abstract][Full Text] [Related]
34. Behind closed doors: the data monitoring board in randomized clinical trials. Wittes J Stat Med; 1993 Mar; 12(5-6):419-24. PubMed ID: 8493420 [TBL] [Abstract][Full Text] [Related]
35. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods. Graves N; Walker D; Raine R; Hutchings A; Roberts JA Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373 [TBL] [Abstract][Full Text] [Related]
36. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle. Browne LH; Graham PH Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199 [TBL] [Abstract][Full Text] [Related]